Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Bonaiti, Giulia ^a   Pesci, Alberto ^a   Marruchella, Almerico ^a   Lapadula, Giuseppe ^b   Gori, Andrea ^b   Aliberti, Stefano ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b AO San Gerardo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; MACROLIDE; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BODY MASS; BRONCHIECTASIS; DISEASE COURSE; DISEASE SEVERITY; EXPOSURE; FOLLOW UP; HUMAN; IMMUNITY; MIXED INFECTION; MONOTHERAPY; NONCYSTIC FIBROSIS BRONCHIECTASIS; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; TREATMENT FAILURE; FIBROSIS; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

CORYNEBACTERINEAE;

BRONCHIECTASIS; FIBROSIS; HUMANS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PSEUDOMONAS AERUGINOSA; RISK FACTORS;

EID: 84935859909     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/197950     Document Type: Review

References (62)

1. E. H. Runyon, "Anonymous mycobacteria in pulmonary disease," The Medical Clinics of North America, vol. 43, no. 1, pp. 273-290, 1959.
2. J. M. Bryant, D. M. Grogono, D. Greaves et al., "Whole-genome sequencing to identify transmission ofMycobacteriumabscessus between patients with cystic fibrosis: a retrospective cohort study," The Lancet, vol. 381, no. 9877, pp. 1551-1560, 2013.
3. W. M. Ricketts, T. C. OShaughnessy, and J. van Ingen, "Humanto-human transmission of Mycobacteriumkansasii or victims of a shared source?" European Respiratory Journal, 2014.
4. D. R. Prevots, P. A. Shaw, D. Strickland et al., "Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems," American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 7, pp. 970-976, 2010.
5. J. E. Moore, M. E. Kruijshaar, L. P. Ormerod, F. Drobniewski, and I. Abubakar, "Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006," BMC Public Health, vol. 10, article 612, 2010.
6. D. S. Price, D. D. Peterson, R. M. Steiner et al., "Infection with Mycobacterium avium complex in patients without predisposing conditions,"The New England Journal of Medicine, vol. 321, no. 13, pp. 863-868, 1989.
7. G. Lee, K. S. Lee, J. W. Moon et al., "Nodular bronchiectatic Mycobacterium avium complex pulmonary disease: natural course on serial computed tomographic scans," Annals of the American Thoracic Society, vol. 10, no. 4, pp. 299-306, 2013.
8. R. M. Thomson, J. G. Armstrong, and D. F. Looke, "Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease," Chest, vol. 131, no. 4, pp. 1166-1172, 2007.
9. M. Mirsaedi, W. Hadid, B. Ericsoussi et al., "NTM disease is common in patients with non cystic fibrosis bronchiectasis," International Journal of Infectious Diseases, vol. 17, no. 11, pp. e1000-e1004, 2013.
10. A. M. Middleton, M. V. Chadwick, A. G. Nicholson et al., "The role of Mycobacterium avium complex fibronectin attachment protein in adherence to the human respiratory mucosa," Molecular Microbiology, vol. 38, no. 2, pp. 381-391, 2000.
11. S. R. Krutzik and R. L. Modlin, "The role of Toll-like receptors in combating mycobacteria," Seminars in Immunology, vol. 16, no. 1, pp. 35-41, 2004.
12. I. Vergne, S. Singh, E. Roberts et al., "Autophagy in immune defense against Mycobacterium tuberculosis," Autophagy, vol. 2, no. 3, pp. 175-178, 2006.
13. S. A. Fulton, J. M. Johnsen, S. F. Wolf, D. S. Sieburth, and W. H. Boom, "Interleukin-12 production by human monocytes infected withMycobacteriumtuberculosis: role of phagocytosis," Infection and Immunity, vol. 64, no. 7, pp. 2523-2531, 1996.
14. M. K. Gately, L. M. Renzetti, J. Magram et al., "The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses," Annual Review of Immunology, vol. 16, pp. 495-521, 1998.
15. K. Kubo, Y. Yamazaki, M. Hanaoka et al., "Analysis of HLA antigens in Mycobacterium avium-intracellulare pulmonary infection," American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 4, part 1, pp. 1368-1371, 2000.
16. M. H. Haverkamp, J. T. van Dissel, and S. M. Holland, "Human host genetic factors in nontuberculousmycobacterial infection: lessons fromsingle gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferongamma-dependent signaling," Microbes and Infection, vol. 8, no. 4, pp. 1157-1166, 2006.
17. J. Keane, "Tumor necrosis factor blockers and reactivation of latent tuberculosis," Clinical Infectious Diseases, vol. 39, no. 3, pp. 300-302, 2004.
18. K. L. Winthrop, E. Chang, S. Yamashita, M. F. Iademarco, and P. A. LoBue, "Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy," Emerging Infectious Diseases, vol. 15, no. 10, pp. 1556-1561, 2009.
19. M. Renna, C. Schaffner, K. Brown et al., "Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection," The Journal of Clinical Investigation, vol. 121, no. 9, pp. 3554-3563, 2011.
20. C. R. Horsburgh Jr., J. Gettings, L. N. Alexander, and J. L. Lennox, "Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000," Clinical Infectious Diseases, vol. 33, no. 11, pp. 1938-1943, 2001.
21. S. D. Lawn, L.-G. Bekker, and R. F. Miller, "Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals," The Lancet Infectious Diseases, vol. 5, no. 6, pp. 361-373, 2005.
22. J. M. Reich and R. E. Johnson, "Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The LadyWindermere syndrome," Chest, vol. 101, no. 6, pp. 1605-1609, 1992.
23. R. D. Kim, D. E. Greenberg, M. E. Ehrmantraut et al., "Pulmonary nontuberculous mycobacterial disease : prospective study of a distinct preexisting syndrome," American Journal of Respiratory and Critical CareMedicine, vol. 178, no. 10, pp. 1066-1074, 2008.
24. T. Bienvenu, I. Sermet-Gaudelus, P.-R. Burgel et al., "Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis," American Journal of Respiratory and Critical CareMedicine, vol. 181, no. 10, pp. 1078-1084, 2010.
25. R. E. Colombo, S. C. Hill, R. J. Claypool, S. M. Holland, and K. N. Olivier, "Familial clustering of pulmonary nontuberculous mycobacterial disease," Chest, vol. 137, no. 3, pp. 629-634, 2010.
26. E. D. Chan, A. M. Kaminska, W. Gill et al., "Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growingmycobacteria andAAT inhibits Mycobacterium abscessus infection of macrophages," Scandinavian Journal of Infectious Diseases, vol. 39, no. 8, pp. 690-696, 2007.
27. K. Suzuki, "Clinical comparison of pulmonary tuberculosis with pulmonary M. avium complex disease," Kekkaku, vol. 70, no. 11, pp. 659-663, 1995.
28. V. Thanachartwet, V. Desakorn, D. Duangrithi et al., "Comparison of clinical and laboratory findings between those with pulmonary tuberculosis and those with nontuberculous mycobacterial lung disease," The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 45, no. 1, pp. 85-94, 2014.
29. J. A. Queipo, E. Broseta, M. Santos, J. Sanchez-Plumed, A. Budia, and F. Jimenez-Cruz, "Mycobacterial infection in a series of 1261 renal transplant recipients," Clinical Microbiology and Infection, vol. 9, no. 6, pp. 518-525, 2003.
30. D. E. Griffith, T. Aksamit, B. A. Brown-Elliott et al., "An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases," American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 4, pp. 367-416, 2007.
31. M. Okumura, K. Iwai, H. Ogata et al., "Pulmonary Mycobacterium avium complex (MAC) disease showing middle lobe syndrome-pathological findings of 2 cases suggesting different mode of development," Kekkaku, vol. 77, no. 9, pp. 615-620, 2002.
32. J. Fujita, Y. Ohtsuki, E. Shigeto et al., "Pathological findings of bronchiectases caused by Mycobacterium avium intracellulare complex," RespiratoryMedicine, vol. 97, no. 8, pp. 933-938, 2003.
33. J. F. Xu and H. Xiao, "Prevalence and clinical analysis of bronchiectasis with NTMlung disease in China," Chest, vol. 145, no. 3, p. 429A, 2014.
34. S. J. Fowler, J. French, N. J. Screaton et al., "Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics," European Respiratory Journal, vol. 28, no. 6, pp. 1204-1210, 2006.
35. P. Seddon, K. Fidler, S. Raman et al., "Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009," Emerging Infectious Diseases, vol. 19, no. 7, pp. 1128-1130, 2013.
36. J. M. Kilby, P. H. Gilligan, J. R. Yankaskas, W. E. Highsmith Jr., L. J. Edwards, and M. R. Knowles, "Nontuberculousmycobacteria in adult patients with cystic fibrosis," Chest, vol. 102, no. 1, pp. 70-75, 1992.
37. K. N. Olivier, D. J. Weber, R. J. Wallace Jr. et al., "Nontuberculous mycobacteria. I:multicenter prevalence study in cystic fibrosis," American Journal of Respiratory and Critical CareMedicine, vol. 167, no. 6, pp. 828-834, 2003.
38. J. A. Yu, M. Pomerantz, A. Bishop, M. J. Weyant, and J. D. Mitchell, "Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease," European Journal of Cardio-Thoracic Surgery, vol. 40, no. 3, pp. 671-675, 2011.
39. W.-J. Koh, K. S. Lee, O. J. Kwon, Y. J. Jeong, S.-H. Kwak, and T. S. Kim, "Bilateral bronchiectasis and bronchiolitis at thin-section CT: diagnostic implications in nontuberculous mycobacterial pulmonary infection," Radiology, vol. 235, no. 1, pp. 282-288, 2005.
40. M. Wickremasinghe, L. J. Ozerovitch, G. Davies et al., "Nontuberculousmycobacteria in patients with bronchiectasis," Thorax, vol. 60, no. 12, pp. 1045-1051, 2005.
41. H. Kunst, M. Wickremasinghe, A. Wells, and R. Wilson, "Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis," European Respiratory Journal, vol. 28, no. 2, pp. 352-357, 2006.
42. I. Ferrara, S. Cappabianca, L. Brunese et al., "HRCT in detection of pulmonary infections from nontuberculous mycobacteria: personal experience," RadiologiaMedica, vol. 114, no. 3, pp. 376-389, 2009.
43. R. J. Wallace Jr., J. L. Cook, J. Glassroth et al., "American Thoracic Society statement: diagnosis and treatment of disease caused by nontuberculous mycobacteria," American Journal of Respiratory and Critical CareMedicine, vol. 156, pp. S1-S25, 1997.
44. J. J. Erasmus, H. P. McAdams, M. A. Farrell, and E. F. Patz Jr., "Pulmonary nontuberculous mycobacterial infection: radiologic manifestations," Radiographics, vol. 19, no. 6, pp. 1487-1505, 1999.
45. C.-C. Shu, C.-H. Lee, C.-L. Hsu et al., "Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns," Lung, vol. 189, no. 6, pp. 467-474, 2011.
46. Z. Zoumot, A. K. Boutou, S. S. Gill et al., "Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis," Respirology, vol. 19, no. 5, pp. 714-722, 2014.
47. S. A. Evans, S. M. Turner, B. J. Bosch, C. C. Hardy, and M. A. Woodhead, "Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa," European Respiratory Journal, vol. 9, no. 8, pp. 1601-1604, 1996.
48. R. J. Wallace Jr., Y. Zhang, B. A. Brown et al., "Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis," American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 4, pp. 1235-1244, 1998.
49. Z. Khan, A. Miller, M. Bachan, and J. Donath, "Mycobacterium avium complex (MAC) lung disease in two inner city community hospitals: recognition, prevalence, co-infection with mycobacterium tuberculosis (MTB) and pulmonary function (PF) improvements after treatment," The Open Respiratory Medicine Journal, vol. 4, no. 1, pp. 76-81, 2010.
50. S. M. Hwang, M. S. Lim, Y. J. Hong et al., "Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculousmycobacteria in respiratory specimens," Tuberculosis, vol. 93, no. 6, pp. 642-646, 2013.
51. F.-C. Bange, P. Kirschner, and E. C. Bottger, "Recovery of mycobacteria from patients with cystic fibrosis," Journal of Clinical Microbiology, vol. 37, no. 11, pp. 3761-3763, 1999.
52. S. Y. Low, M. S. Koh, T. H. Ong et al., "Use of endobronchial ultrasound-guided transbronchial needle aspiration (EBUSTBNA) in the diagnosis of granulomatous mediastinal lymphadenopathy," Annals Academy of Medicine, vol. 43, no. 5, pp. 250-254, 2014.
53. M. Slany and I. Pavlik, "Molecular detection of nontuberculous mycobacteria: advantages and limits of a broad-range sequencing approach," Journal of Molecular Microbiology and Biotechnology, vol. 22, no. 4, pp. 268-276, 2012.
54. E. H. Moore, "Atypical mycobacterial infection in the lung: CT appearance," Radiology, vol. 187, no. 3, pp. 777-782, 1993.
55. K. McKlendin and P. Stark, "Mycobacterium avium intracellulare complex as a cause of bronchiectasis," Seminars in Respiratory Infections, vol. 16, no. 1, pp. 85-87, 2001.
56. L. Woods, B. Brown-Elliott, and P. Conville, Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes, Clinical and Laboratory Standards Institute (CLSI), 2nd edition, 2011.
57. D. E. Griffith and T. R. Aksamit, "Bronchiectasis and nontuberculousmycobacterial disease," Clinics in ChestMedicine, vol. 33, no. 2, pp. 283-295, 2012.
58. R. J. Wallace Jr., B. A. Brown-Elliott, S. McNulty et al., "Macrolide/azalide therapy for nodular/bronchiectatic: MAC lung disease," Chest, vol. 146, no. 2, pp. 276-282, 2014.
59. R. J. Wallace Jr., Y. Zhang, B. A. Brown-Elliott et al., "Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis," The Journal of Infectious Diseases, vol. 186, no. 2, pp. 266-273, 2002.
60. S. Kitada, T. Uenami, K. Yoshimura et al., "Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease," International Journal of Tuberculosis and Lung Disease, vol. 16, no. 5, pp. 660-664, 2012.
61. M. Sato, T. Hiyama, K. Kaito, Y. Hayashi, and T. Okumura, "Usefulness of F-18 FDG PET/CT in the assessment of disseminated Mycobacterium avium complex infection," Annals of Nuclear Medicine, vol. 23, no. 8, pp. 757-762, 2009.
62. J. Drijkoningen, H. van der Pol, and M. de Vries, "PET scanning used for monitoring treatment response in Mycobacterium avium complex infection mimicking malignancy," Clinical Nuclear Medicine, vol. 34, no. 11, pp. 818-820, 2009.